Literature DB >> 18802062

Differential susceptibility of allogeneic targets to indirect CD4 immunity generates split tolerance.

William F N Chan1, Haide Razavy, Colin C Anderson.   

Abstract

CD4 T cells frequently help to activate CD8 T and B cells that effect transplant rejection. However, CD4 T cells alone can reject transplants, either directly or indirectly. The relative effectiveness of indirect CD4 immunity in rejecting different types of allogeneic grafts is unknown. To address this, we used a TCR transgenic mouse model in which indirect CD4 alloimmunity alone can be studied. We challenged transgenic recipients with hematopoietic cells and shortly thereafter skin transplants that could only be rejected indirectly, and observed Ag-specific indirect donor B cell and skin rejection, but not T cell elimination, reflecting a state of split tolerance. Deficiency of indirect CD4 alloimmunity in donor T cell rejection was also apparent when acute indirect rejection of donor islets occurred despite generation and maintenance of mixed T cell chimerism, due to migration of the few passenger T cells into recipient circulation. Although passenger lymphocytes delayed indirect islet rejection, they enhanced rejection by a full repertoire capable of both direct and indirect reactivity. Interestingly, the persistence of chimerism was associated with the eventual development of tolerance, as demonstrated by acceptance of donor skin grafts given late to hematopoietic cell recipients, and hyporesponsiveness of transgenic T cells from islet recipients in vitro. Mechanistically, tolerance was recessive and associated with progressive down-regulation of CD4. Collectively, our data indicate that indirect CD4 immunity is not equally destructive toward different types of allogeneic grafts, the deficiency of which generates split tolerance. The futility of these responses can convert immunity into tolerance.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18802062     DOI: 10.4049/jimmunol.181.7.4603

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Correlation between post transplant maternal microchimerism and tolerance across MHC barriers in mice.

Authors:  Partha Dutta; William J Burlingham
Journal:  Chimerism       Date:  2011-07-01

2.  Comment on: Ten experiments that would make a difference in understanding immune mechanisms.

Authors:  Colin C Anderson
Journal:  Cell Mol Life Sci       Date:  2011-11-25       Impact factor: 9.261

Review 3.  Mixed chimerism and split tolerance: mechanisms and clinical correlations.

Authors:  David P Al-Adra; Colin C Anderson
Journal:  Chimerism       Date:  2011 Oct-Dec

4.  Co-inhibitory molecules: Controlling the effectors or controlling the controllers?

Authors:  Govindarajan Thangavelu; Christa Smolarchuk; Colin C Anderson
Journal:  Self Nonself       Date:  2010-02-16

5.  Apelin directs endothelial cell differentiation and vascular repair following immune-mediated injury.

Authors:  Andrew G Masoud; Jiaxin Lin; Abul K Azad; Maikel A Farhan; Conrad Fischer; Lin F Zhu; Hao Zhang; Banu Sis; Zamaneh Kassiri; Ronald B Moore; Daniel Kim; Colin C Anderson; John C Vederas; Benjamin A Adam; Gavin Y Oudit; Allan G Murray
Journal:  J Clin Invest       Date:  2020-01-02       Impact factor: 14.808

6.  The role of co-inhibitory signals in spontaneous tolerance of weakly mismatched transplants.

Authors:  Govindarajan Thangavelu; Kenneth M Murphy; Hideo Yagita; Louis Boon; Colin C Anderson
Journal:  Immunobiology       Date:  2011-01-12       Impact factor: 3.144

7.  Microchimerism is strongly correlated with tolerance to noninherited maternal antigens in mice.

Authors:  Partha Dutta; Melanie Molitor-Dart; Joseph L Bobadilla; Drew A Roenneburg; Zhen Yan; Jose R Torrealba; William J Burlingham
Journal:  Blood       Date:  2009-08-21       Impact factor: 22.113

8.  Polyclonal Recipient nTregs Are Superior to Donor or Third-Party Tregs in the Induction of Transplantation Tolerance.

Authors:  Nina Pilat; Christoph Klaus; Karin Hock; Ulrike Baranyi; Lukas Unger; Benedikt Mahr; Andreas M Farkas; Fritz Wrba; Thomas Wekerle
Journal:  J Immunol Res       Date:  2015-07-27       Impact factor: 4.818

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.